New pill trial aims to stop inherited breast Cancer's return
NCT ID NCT07353437
Summary
This study is testing if adding a pill called fluzoparib to standard care helps prevent breast cancer from returning in women who have already had surgery. It is for women with early-stage breast cancer who have specific inherited gene mutations. The goal is to see if taking the pill for one year, along with their doctor's chosen standard treatment, keeps them cancer-free longer than standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.